Virtu KCG Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Virtu KCG Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,300	Closed	-$377K	–	3496
2014 Q4	$377K	Buy	2,300 +100	+5%	+$16.6K	0.01%	2055
2014 Q3	$353K	Sell	2,200 -3,200	-59%	-$492K	0.01%	2124
2014 Q2	$794K	Sell	5,400 -11,500	-68%	-$1.59M	0.01%	1423
2014 Q1	$2.34M	Buy	16,900 +11,200	+196%	+$1.69M	0.03%	593
2013 Q4	$721K	Buy	5,700 +1,700	+43%	+$176K	0.01%	1538
2013 Q3	$368K	Buy	+4,000	New	+$323K	﹤0.01%	2376

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Virtu KCG Holdings's JAZZ Position: Q2 2017 in Review

Virtu KCG Holdings increased its Jazz Pharmaceuticals (JAZZ) stake by 116% in Q2 2017, buying an estimated $1.05M and bringing the position to 12,751 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #255.

Virtu KCG Holdings first reported a position in JAZZ in Q3 2013 and has held it in 15 quarters since. 319 funds tracked by Wall St. Rank hold JAZZ as of Q2 2017.

Virtu KCG Holdings held 12,751 shares of Jazz Pharmaceuticals worth $1.98M as of Q2 2017.
Virtu KCG Holdings bought 6,847 Jazz Pharmaceuticals shares in Q2 2017, an estimated $1.05M.
Jazz Pharmaceuticals made up 0.06% of Virtu KCG Holdings's portfolio in Q2 2017, its #255 holding.
Virtu KCG Holdings first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 15 quarters since.
319 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.